WHO ICTRP trial
Effect of citalopram on chest pain in patients with achalasia.
CTIS2024-517701-81-01 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-517701-81-01 |
|---|---|
| Public title | Effect of citalopram on chest pain in patients with achalasia. |
| Scientific title | Effect of citalopram on chest pain in patients with achalasia. |
| Primary sponsor | Amsterdam UMC Stichting |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): Yes |
| Countries | Netherlands |
| Conditions | Achalasia;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Product Name: Citalopram CF 20 mg, filmomhulde tabletten, Product Code:PRD385917, Pharmaceutical Form: FILM-COATED TABLET, Other descriptive name: , Strength: , Product Name: Placebo of citalopram 20mg, Product Code:N/A, Pharmaceutical… |
| Registration date | Nov 29, 2024 |
| Target size | 48 |
| Secondary IDs | 2019-001202-14;NL-OMON48367 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: